Drug reference

acoziborole

Antiparasitic

CDSCO approved

EXCRETION

—

not curated

INTERACTIONS

—

none in our sources

PREGNANCY

—

not curated

Mechanism

Not yet extracted

Indications

First-stage T. b. gambiense HATSecond-stage T. b. gambiense HAT

Dosing

Adult: Single-dose treatment (three tablets) (oral).

Related guidelines

Stroke and TIA — secondary prevention

AHA · Neurology · 2021

Dyslipidaemia management

ICMR · Cardiology · 2023

Breast cancer

ESMO · Oncology · 2024

Beta-blockers in hypertension

MOHFW · Cardiology · 2024

Gestational diabetes mellitus

FOGSI · Obstetrics & Gynaecology · 2023

Other Unclassified drugs

5-9-tetrahydrocannabinol

adrenochrome monosemicarbazone

0 brands

alcohol

0 brands

Ask House about acoziborole

Continue into a citation-backed clinical answer with the drug context already attached.

Open in workspace Ask House about this drug

Sources: Harrison 22e·Verified: 2026-05-10 · House clinical team